In situ vaccination for the treatment of cancer

被引：85

作者：

Hammerich, Linda ^{[1
]}

Bhardwaj, Nina ^{[1
]}

Kohrt, Holbrook E. ^{[2
]}

Brody, Joshua D. ^{[1
]}

机构：

[1] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA

[2] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA

来源：

IMMUNOTHERAPY | 2016年 / 8卷 / 03期

关键词：

autologous DC; cytokine; Flt3L; in situ vaccine; oncolytic virus; TLR agonist; tumor-associated antigen; COLONY-STIMULATING FACTOR; HERPES-SIMPLEX-VIRUS; TUMOR-ASSOCIATED VASCULATURE; ENHANCES ANTITUMOR EFFICACY; TARGETED ONCOLYTIC POXVIRUS; LOW-DOSE CYCLOPHOSPHAMIDE; FOLLICLE CENTER LYMPHOMA; RENAL-CELL CARCINOMA; INTRATUMORAL INJECTION; DENDRITIC CELLS;

D O I：

10.2217/imt.15.120

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Vaccination has had a tremendous impact on human health by harnessing the immune system to prevent and eradicate infectious diseases and this same approach might be used in cancer therapy. Cancer vaccine development has been slowed hindered by the paucity of universal tumor-associated antigens and the difficulty in isolating and preparing individualized vaccines ex vivo. Another approach has been to initiate or stimulate an immune response in situ (at the tumor site) and thus exploit the potentially numerous tumor-associated antigens there. Here, we review the many approaches that have attempted to accomplish effective in situ vaccination, using intratumoral administration of immunomodulators to increase the numbers or activation state of either antigen present cells or T cells within the tumor.

引用

页码：315 / 330

页数：16

共 153 条

[91] Mobilization of dendritic cell precursors in patients with cancer by Flt3 ligand allows the generation of higher yields of cultured dendritic cells [J].

Marroquin, CE ;

Westwood, JA ;

Lapointe, R ;

Mixon, A ;

Wunderlich, JR ;

Caron, D ;

Rosenberg, SA ;

Hwu, P .

JOURNAL OF IMMUNOTHERAPY, 2002, 25 (03) :278-288

[92] Preoperative mobilization of circulating dendritic cells by Flt3 ligand administration to patients with metastatic colon cancer [J].

Morse, MA ;

Nair, S ;

Fernandez-Casal, M ;

Deng, YP ;

St Peter, M ;

Williams, R ;

Hobeika, A ;

Mosca, P ;

Clay, T ;

Cumming, RI ;

Fisher, E ;

Clavien, P ;

Proia, AD ;

Niedzwiecki, D ;

Caron, D ;

Lyerly, HK .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (23) :3883-3893

[93]

Motoyoshi Y, 2006, ONCOL REP, V16, P141

[94] In situ vaccination against a non-immunogenic tumour using intratumoural injections of liposomal interleukin 2 [J].

Neville, ME ;

Robb, RJ ;

Popescu, MC .

CYTOKINE, 2001, 16 (06) :239-250

[95] Tumor-derived heat shock protein 70 peptide complexes are cross-presented by human dendritic cells [J].

Noessner, E ;

Gastpar, R ;

Milani, V ;

Brandl, A ;

Hutzler, PJS ;

Kuppner, MC ;

Roos, M ;

Kremmer, E ;

Asea, A ;

Calderwood, SK ;

Issels, RD .

JOURNAL OF IMMUNOLOGY, 2002, 169 (10) :5424-5432

[96] The Oncolytic Poxvirus JX-594 Selectively Replicates in and Destroys Cancer Cells Driven by Genetic Pathways Commonly Activated in Cancers [J].

Parato, Kelley A. ;

Breitbach, Caroline J. ;

Le Boeuf, Fabrice ;

Wang, Jiahu ;

Storbeck, Chris ;

Ilkow, Carolina ;

Diallo, Jean-Simon ;

Falls, Theresa ;

Burns, Joseph ;

Garcia, Vanessa ;

Kanji, Femina ;

Evgin, Laura ;

Hu, Kang ;

Paradis, Francois ;

Knowles, Shane ;

Hwang, Tae-Ho ;

Vanderhyden, Barbara C. ;

Auer, Rebecca ;

Kirn, David H. ;

Bell, John C. .

MOLECULAR THERAPY, 2012, 20 (04) :749-758

[97] Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial [J].

Park, Byeong-Ho ;

Hwang, Taeho ;

Liu, To-Chiang ;

Sze, Daniel Y. ;

Kim, Jae-Seok ;

Kwon, Hyuk-Chan ;

Oh, Sung Yong ;

Han, Sang-Young ;

Yoon, Jin-Han ;

Hong, Sook-Hee ;

Moon, Anne ;

Speth, Kelly ;

Park, Chohee ;

Ahn, Young-Joo ;

Daneshmand, Manijeh ;

Rhee, Byung Geon ;

Pinedo, Herbert M. ;

Bell, John C. ;

Kirn, David H. .

LANCET ONCOLOGY, 2008, 9 (06) :533-542

[98] In vitro tumor-pulsed or in vivo Flt3 ligand-generated dendritic cells provide protection against acute myelogenous leukemia in nontransplanted or syngeneic bone marrow-transplanted mice [J].

Pawlowska, AB ;

Hashino, S ;

McKenna, H ;

Weigel, BJ ;

Taylor, PA ;

Blazar, BR .

BLOOD, 2001, 97 (05) :1474-1482

[99] Oncolytic Immunotherapy of Advanced Solid Tumors with a CD40L-Expressing Replicating Adenovirus: Assessment of Safety and Immunologic Responses in Patients [J].

Pesonen, Sari ;

Diaconu, Iulia ;

Kangasniemi, Lotta ;

Ranki, Tuuli ;

Kanerva, Anna ;

Pesonen, Saila K. ;

Gerdemann, Ulrike ;

Leen, Ann M. ;

Kairemo, Kalevi ;

Oksanen, Minna ;

Haavisto, Elina ;

Holm, Sirkka-Liisa ;

Karioja-Kallio, Aila ;

Kauppinen, Satu ;

Partanen, Kaarina P. L. ;

Laasonen, Leena ;

Joensuu, Tima ;

Alanko, Tuomo ;

Cerullo, Vincenzo ;

Hemminki, Akseli .

CANCER RESEARCH, 2012, 72 (07) :1621-1631

[100]

Puzanov I, 2014, ASCO M, V32, P9029, DOI DOI 10.1200/JC0.2013.49.4757

← 5 6 7 8 9 10 11 12 13 14 →